Home
Publishing
DrugRxiv
Drug Repurposing
Network Medicine
About
REPO4EU
Meet the team
Drug Repurposing Research Collection
Conference
Blog
My ScienceOpen
Sign in
Register
Dashboard
Search
Home
Publishing
DrugRxiv
Drug Repurposing
Network Medicine
About
REPO4EU
Meet the team
Drug Repurposing Research Collection
Conference
My ScienceOpen
Sign in
Register
Dashboard
Search
5
views
31
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
5,186
similar
All similar
Record
: found
Abstract
: not found
Book Chapter
: not found
The Regulation of Human Germline Genome Modification in the Netherlands
edited_book
Author(s):
Britta van Beers
,
Charlotte de Kluiver
,
Rick Maas
Publication date:
January 31 2020
Publisher:
Cambridge University Press
Read this book at
Publisher
Further versions
oa repository (via OAI-PMH doi match)
oa repository (via OAI-PMH doi match)
Powered by
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Genome Integrity
Most cited references
31
Record
: found
Abstract
: not found
Book
: not found
Persoon en lichaam in het recht. Menselijke waardigheid enzelfbeschikking in het tijdperk van de medische biotechnologie
BC Beers Van
,
van Beers
(2009)
0
comments
Cited
2
times
– based on
0
reviews
Bookmark
Record
: found
Abstract
: not found
Book
: not found
Evaluatie Embryowet en Wet donorgegevens kunstmatige bevruchting
Winter
(2012)
0
comments
Cited
2
times
– based on
0
reviews
Bookmark
Record
: found
Abstract
: not found
Book
: not found
Basic Ethical Principles in European Bioethics and Biolaw
(2000)
0
comments
Cited
2
times
– based on
0
reviews
Bookmark
All references
Author and book information
Book Chapter
Publication date:
January 31 2020
Pages
: 309-334
DOI:
10.1017/9781108759083.012
SO-VID:
f31a7502-6e7b-4feb-8b54-a231447ea82f
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. 1
Introduction
pp. 22
The Governance of Human (Germline) Genome Modification at the International and Transnational Levels
pp. 83
The Regulation of Human Germline Genome Modification in Canada
pp. 103
The Regulation of Human Germline Genome Modification in the United States
pp. 129
The Regulation of Human Germline Genome Modification in Mexico
pp. 155
The Regulation of Human Germline Genome Modification in Europe
pp. 217
The Regulation of Human Germline Genome Modification in the United Kingdom
pp. 241
The Regulation of Human Germline Genome Modification in Germany
pp. 266
The Regulation of Human Germline Genome Modification in Belgium
pp. 281
The Regulation of Human Germline Genome Modification in Sweden
pp. 309
The Regulation of Human Germline Genome Modification in the Netherlands
pp. 335
The Regulation of Human Germline Genome Modification in Italy
pp. 358
The Regulation of Human Germline Genome Modification in Spain
pp. 409
The Regulation of Human Germline Genome Modification in Switzerland
pp. 441
The Regulation of Human Germline Genome Modification in Japan
pp. 469
The Regulation of Human Germline Genome Modification in the People’s Republic of China
pp. 500
The Regulation of Human Germline Genome Modification in the Republic of Korea
pp. 516
The Regulation of Human Germline Genome Modification in Singapore
pp. 543
The Regulation of Human Germline Genome Modification in Australia
pp. 568
The Regulation of Human Germline Genome Modification in Israel
pp. 585
Toward a Human Rights Framework for the Regulation of Human Germline Genome Modification
pp. 618
Index
Similar content
5,186
Necrocarcinus ornatissimus Forir, 1887, and Prehepatus werneri Fraaye & Collins, 1987 (Upper Maastrichtian, The Netherlands) revisited, with Notes on other Cretaceous dynomenid crabs (Decapoda, Brachyura)
Authors:
J.W.M. JAGT
,
R.H.B. Fraaije
,
B.W.M. Van Bakel
…
Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients.
Authors:
Kimberly DeLeonardis
,
Kristin Sedgwick
,
Olga Voznesensky
…
Dynamics in business models: An empirical analysis of medical biotechnology firms in the Netherlands
Authors:
M.T.H. Meeus
,
L. Willemstein
,
T. van der Valk
See all similar